Wu Jieping Medical Foundation-Bioheal Regenerative Surgery Excellence Fund to Launch in Hangzhou

The “Wu Jieping Medical Foundation–Biosis Healing Excellence in Surgery Special Fund,” jointly established by the Wu Jieping Medical Foundation and Beijing Biosis Healing Biological Technology Co., Ltd. (hereinafter referred to as “Biosis Healing”), will be officially launched at the joint conference of the Annual Meeting of the Chinese Journal of Hernia and Abdominal Wall Surgery, the 4th Qianjiang Hernia Forum, and the Annual Meeting of the Hernia and Abdominal Wall Surgery Industry and Clinical Research Branch of the China Health Industry Enterprise Management Association, to be held in Hangzhou on March 21, 2019.

This landmark initiative by Beijing Biosis Healing Biological Technology Co., Ltd. in the realm of charitable surgical care is poised to provide substantial impetus to the development of philanthropy in surgical medicine. The launch ceremony was attended by Chairman Xiao Meng and Chen Linjun, Director of the Science and Technology Department, of the Wu Jieping Medical Foundation. Distinguished expert committee members included Professor Chen Jie from Beijing Chaoyang Hospital, Capital Medical University, and Professor Tang Jianxiong from Huadong Hospital, Fudan University, who engaged in in-depth discussions on topics such as the Excellence in Surgery Special Fund and the advancement of surgical disciplines.

Wu Jieping Medical Foundation - Biosis Healing Excellence in Surgery Special Fund

Introduction to the Expert Review Committee Members

Chen Jie

Director, Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University

M.D.; Chief Physician; Professor; Doctoral Supervisor

Editor-in-Chief of Chinese Journal of Hernia and Abdominal Wall Surgery (Electronic Edition)

Tang Jianxiong

Huadong Hospital Affiliated to Fudan University; Director of the Department of General Surgery; Director of the Department of General Surgery; Chief Physician

Associate Chair, Department of Surgery, Shanghai Medical College, Fudan University; Professor; Master’s Supervisor

Li Jianwen

Chief Physician, Department of Gastrointestinal Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Director, Center for Hernia and Abdominal Wall Surgery

Deputy Director, Shanghai Clinical Medical Center for Minimally Invasive Surgery

Shuang Chen

The Sixth Affiliated Hospital of Sun Yat-sen University Chief Physician; Professor; Doctoral Supervisor

Department Director; Director of the Department of Surgery for Teaching and Research

Studied under the renowned Chinese surgeon Professor Lin Yanjian.

Pioneer of Tension-Free Hernia Repair in China

Liu Ziwen

Peking Union Medical College Hospital Pancreatic Surgery Center Chief Physician

M.D.

Visiting Scholar, School of Medicine, Southern Illinois University

Studied under Professor Zhao Yupei, Academician of the Chinese Academy of Sciences

Shen Yingmo

Beijing Chaoyang Hospital, Capital Medical University – Deputy Director, Department of Hernia and Abdominal Wall Surgery

Chief Physician, Professor, Master's Supervisor

Deputy Editor-in-Chief and Director of the Editorial Office, Chinese Journal of Hernia and Abdominal Wall Surgery (Electronic Edition)

The special fund was officially established and signed on February 27, 2019, by Wu Jieping Medical Foundation Chairman Xiao Meng and Beijing Biosis Healing Biological Technology Co., Ltd. Chairman Zhao Bo.

Prior to the signing of this special fund, Beijing Biosis Healing Biological Technology Co., Ltd. had been consistently dedicated to advancing medical public welfare initiatives. Since its establishment in 2012, the company has adhered to its original mission of promoting human health and well-being. While achieving rapid growth, it has remained committed to making proactive efforts in the realm of public welfare, thereby making unique contributions to fostering the healthy development of the industry and advancing philanthropic causes.

Biosis Healing and the Wu Jieping Medical Foundation have long maintained a deep partnership. During their collaboration, both parties recognized the need to elevate their shared ambition for the medical cause to new heights. Consequently, they swiftly reached a consensus and accelerated the establishment of the “Wu Jieping Medical Foundation–Biosis Healing Excellence in Surgery Special Fund.”

The establishment of the special fund, with the primary objective of enhancing China’s technological and industrialization capabilities in this field, aims to break the monopoly held by foreign technologies, achieve import substitution, and provide high-quality, affordable tissue repair products to a broad patient population. As is well known, tissue repair and functional regeneration have become an inevitable trend in the development of modern surgery. The clinical demand for improving quality of life and restoring the function of defective tissues is growing increasingly strong. Therefore, China’s 13th Five-Year Plan for Scientific and Technological Innovation explicitly states that strategic emphasis should be placed on major strategic products such as tissue-inducing biomedical materials, with a focus on tissue replacement, functional restoration, and intelligent regulation.

However, China’s technological and industrialization capabilities in this field remain weak. Technologies and products for biomedical materials capable of achieving functional regenerative repair are monopolized by a few developed countries, with imported products being prohibitively expensive. Given the substantial clinical demand in China, it is of great significance to rapidly enhance domestic technological proficiency, break the monopoly of imported products, and achieve import substitution. This requires collaborative efforts across upstream and downstream industries, as well as among academia, research institutions, industry, and healthcare providers, to address common key technical and clinical challenges in this field. The establishment of a special-purpose fund is therefore timely.

To ensure the academic integrity and impartiality of research projects under the Wu Jieping Medical Foundation–Biosis Healing Excellence in Surgery Special Fund, the Foundation has established a dedicated Review Expert Committee. This committee will provide independent, academic, fair, impartial, and professionally authoritative opinions on project initiation, review, and evaluation for the Wu Jieping Medical Foundation–Biosis Healing Excellence in Surgery Special Fund.

Appendix: Basic Information on the Conference

I. Time and Venue:

Time: March 21, 17:30–18:30;

Venue: Hongbin Hall, 1st Floor, Hangzhou Diefei Wanghu Hotel

；

II. Co-organizers:

Wu Jieping Medical Foundation

Beijing Biosis Healing Biological Technology Co.,Ltd

Medical Device Branch, Pharmaceutical Industry Chamber of Commerce, All-China Federation of Industry and Commerce

Scan the QR code for more information.